Steven Kanner
Known title: Chief Scientific OfficerCIK: 0001871131
Steven Kanner's purchase track record
Steven Kanner has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/12/2021 | CRBU | $221K | -36.9% | -62.0% | +1.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CRBU | ▼ Sell | Open Market | 3,564 | $5K | 2/21/2025 | View on chart |
| CRBU | ▲ Buy | Grant | 37,500 | $0 | 2/20/2025 | View on chart |
| CRBU | ▲ Buy | Grant | 33,000 | $0 | 2/20/2024 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 30,577 | $82K | 2/6/2024 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 21,401 | $58K | 12/2/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 43,248 | $116K | 8/25/2022 | View on chart |
| CRBU | ▼ Sell | Open Market | 43,248 | $485K | 8/25/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 68,306 | $124K | 5/13/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 6,114 | $16K | 5/13/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 9,171 | $25K | 3/4/2022 | View on chart |
| CRBU | ▲ Buy | Option Exercise | 1,549 | $6K | 3/4/2022 | View on chart |
| CRBU | ▲ Buy | Open Market | 99,548 | $180K | 10/12/2021 | View on chart |
| CRBU | ▲ Buy | Open Market | 14,614 | $39K | 10/12/2021 | View on chart |
| CRBU | ▲ Buy | Open Market | 698 | $1K | 10/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
No recent news for Caribou Biosciences (CRBU)
There are no recent news releases specifically about Caribou Biosciences in the past week. The stock remains unchanged in terms of public announcements. Technical indicators show RSI at 35.1 and support around $1.59, but without new information the market context is limited.
No recent news for Caribou Biosciences (CRBU). There are no recent news releases specifically about Caribou Biosciences in the past week. The stock remains unchanged in terms of public announcements. Technical indicators show RSI at 35.1 and support around $1.59, but without new information the market context is limited.